On cusp of exponential growth with 5% mo-over-mo rev growth?
2022 ended with 5% month-over-month revenue growth, that the company claims should be maintained or exceeded in 2023. Simple math (5% x 12) puts that at 60% growith for the year, but 5% compounded 12 times comes out at about 80% over a year. Should they achieve a 6% month-over-month revenue growth rate that compounds to 100% growth per year - hence my use of the term exponential.
To my mind it's taken a strangely long time to get to this point, given the advantages over surgery and radiation. But the medical professionals involved can be a conservative lot. Apparently those giving the treatments have often tempered their enthusiasm with a desire to actually see the clincal trial results replicated with their own patients. As these personal confirmations of efficacy are taking place, perhaps we'll finally see exponential growth.
-GLTA